Irvine, CA · Founded 2019 · Privately Held (backing)
Developer of stem cell-derived therapy designed to treat age and disease-related immune decline. Immunis is based in Irvine, CA and was founded in 2019. Its last known valuation is $75 million. It has raised $37 million across 2 recorded rounds; the latest was a $12 million early-stage round in May 2026.
Last price · $/share
—
Implied valuation
$75.0M
Total raised
$37.0M
Last round
Early Stage VC
May 2026
Team — not yet on record
No current team members for Immunis are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Immunis with a free account
·The complete investor list: 12 names
·Watch Immunis: the Monday email on marks, rounds and moves
